David Barros-Aguirre

This inventor holds 7 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Anacor Pharmaceuticals, Inc., Glaxosmithkline Intellectual Property (No.2) Limited, Glaxo Group Limited. Active years: 2012-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Barros-Aguirre. Retrieved from https://idiyas.com/inventor/david-barros-aguirre

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 5)

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 4 (Patent Applications = 7)

Average Co-Inventor Count = 6.5

ph-index = 1

Forward Citations = 4(Granted Patents)

Location History:

Research Triangle Park, NC (US) (2012)
Madrid, ES (2012 - 2020)
Tres Cantos, ES (2020 - 2022)

Company Filing History:

5 out of 70

Anacor Pharmaceuticals, Inc.

patents

5 out of 95

Glaxosmithkline Intellectual Property (No.2) Limited

where one patent can have more than one assignee

Years Active: 2012-2022

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11214582 - 4-substituted benzoxaborole compounds and uses thereof (2022-01-04),

2. 10858376 - Tricyclic benzoxaborole compounds and uses thereof (2020-12-08),

3. 10774096 - 4-substituted benzoxaborole compounds and uses thereof (2020-09-15),

4. 10526352 - Tricyclic benzoxaborole compounds and uses thereof (2020-01-07),

5. 10308668 - Tricyclic benzoxaborole compounds and uses thereof (2019-06-04),

6. 8318940 - Naphthyridin-2 (1 H)-one compounds useful as antibacterials (2012-11-27),

7. 8097628 - Compounds (2012-01-17),

Title: Unveiling the Innovative Mind of David Barros-Aguirre

Introduction:

David Barros-Aguirre, a distinguished inventor based in Madrid, Spain, has made significant strides in the field of pharmaceuticals with his groundbreaking innovations.

Latest Patents:

Among his impressive portfolio of patents, David's recent inventions include 4-substituted benzoxaborole compounds with diverse therapeutic uses and tricyclic benzoxaborole compounds tailored for combating mycobacterial infections.

Career Highlights:

Throughout his career, David has accumulated a total of 7 patents, showcasing his expertise and dedication to advancing pharmaceutical research and development. His keen focus on innovation has resulted in patents that have the potential to revolutionize medical treatments.

Collaborations:

David has collaborated with reputable companies such as GlaxoSmithKline Intellectual Property (no.2) Limited and Anacor Pharmaceuticals, Inc., working alongside skilled professionals like Vincent S. Hernandez and Jacob J. Plattner to bring his inventions to fruition.

Conclusion:

David Barros-Aguirre's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor. His contributions to the field continue to inspire and pave the way for future generations of inventors.

Profile summary based on public USPTO records.